Perceive Biotherapeutics

Perceive Biotherapeutics

Signal active

Organization

Contact Information

Overview

Perceive Biotherapeutics is a biotechnology company pioneering novel technologies and therapeutics in ophthalmology.

About

Industries

Biotechnology, Life Science, Biopharma, Therapeutics

Founded

2020

Employees

1-10

Headquarters locations

United States, North America

Social

N/A

Profile Resume

Perceive Biotherapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Biopharma, Therapeutics sector. The company focuses on Biotechnology and has secured $1.2B in funding across 16 round(s). With a team of 1-10 employees, Perceive Biotherapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Perceive Biotherapeutics, raised $78.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Anne Rubin

Anne Rubin

President, Board Member and Co-Founder

Funding Rounds

Funding rounds

1

Investors

5

Lead Investors

0

Total Funding Amount

$78.0M

Details

1

Perceive Biotherapeutics has raised a total of $78.0M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2023Early Stage Venture78.0M

Investors

Perceive Biotherapeutics is funded by 8 investors.

Investor NameLead InvestorFunding RoundPartners
Perceive Biotherapeutics-FUNDING ROUND - Perceive Biotherapeutics78.0M
Deerfield-FUNDING ROUND - Deerfield78.0M
Perceive Biotherapeutics-FUNDING ROUND - Perceive Biotherapeutics78.0M
Braidwell-FUNDING ROUND - Braidwell78.0M

Recent Activity

There is no recent news or activity for this profile.